A Multi-Concept Theme for Digital Agencies and Startups
Ministry of Health and Family Welfare has issued a directive to ban the manufacture, sale, and distribution of the fixed dose combination drug Amylase + Protease + Glucoamylase + Pectinase + Alpha Galactosidase + Lactase + Beta-Gluconase + Cellulase + Lipase + Bromelain + Xylanase + Hemicellulase + Malt diastase + Invertase + Papain, Antimony Potassium Tartrate + Dried Ferrous Sulphate, Benfotiamine + Silymarin + L-Ornithine L-aspartate + Sodium Selenite + Folic acid + Pyridoxine hydrochloride, Bismuth Ammonium Citrate + Papain, Cyproheptadine HCl + Thiamine HCl + Riboflavine + Pyridoxine HCl + Niacinamide, Cyproheptadine Hydrochloride + Tricholine Citrate + Thiamine Hydrochloride + Riboflavine + Pyridoxine Hydrochloride, Rabeprazole Sodium (As enteric coated tablet) + Clidinium Bromide + Dicyclomine HCl + Chlordiazepoxide, Fungal Diastase + Papain + Nux vomica Tincture + Cardamom Tincture + Casein Hydrolysed + Alcohol, Mefenamic Acid + Paracetamol Injection, Omeprazole Magnesium + Dicyclomine HCl, S-adenosyl methionine + Metadoxine + Ursodeoxycholicacid BP + L-Methylfolate Calcium eq. to L-Methylfolate + Choline bitartratee + Silymarin + L-ornithine L-aspartate + Inositol + Taurine, Silymarin + Thiamine Mononitrate + Riboflavin+ Pyridoxine HCl + Niacinamide + Calcium pantothenate + Vitamin B12, Silymarin + Pyridoxine HCl + Cyanocobalamin + Niacinamide + Folic Acid, Silymarin + Vitamin B6 + Vitamin B12 + Niacinamide + Folic acid + Tricholine Citrate for human use. By virtue of the circular, this action is based on recommendations from the Drugs Technical Advisory Board and the powers granted under section 26A of the Drugs and Cosmetics Act, 1940. The drug is deemed to have no therapeutic benefit and may pose risks to human health. Please refer to the attached document for more details.
Request a Demo
SEBI has issued press release on “Samajh Se Investing Simple†Campaign under Project Jagrook Through this Press Release, The ca
NSE has reiterated the circular issued by SEBI regarding Introduction of Credit Risk-o-Meter as an additional disclosure mechanism for debt
NSDL has reiterated the circular issued by SEBI regarding Master Circular for Debenture Trustees Through this circular, Issuers and RTAs ar
BSE has issued circular regarding Cyber Audit on Half Yearly basis for Audit Period ending September 30, 2026 Through this circular, with r
The Government of Chhattisgarh has declared snakebite and death due to snakebite as notifiable diseases throughout the State under Sections
The Department of Industries, Government of Bihar, has notified the implementation of Section 27 read with Schedule VII of the Bihar Ease of
CBIC has issued circular regarding clarification on the scope of “Power Bank†for Basic Customs Duty Concession on Battery Energ
Thank You for your interest in Complinity. Your CV has been forwarded to HR. In case your profile is shortlisted, HR shall contact you.
Thank You for your interest in Complinity. Your CV has been forwarded to HR.